About
Xbrane Biopharma AB is a biotechnology company that develops biosimilars and says it has a patented platform technology for lower-cost production of biological drugs. It is based in Stockholm, Sweden, and focuses on bringing biosimilar medicines through development and commercial supply activities.
Services
Biosimilar development
Develops biosimilars, or follow-up drugs to already approved biological medicines after patent expiry.
Protein production
Uses its platform technology and expertise in protein production to support biosimilar development and manufacturing.
Analytical methods
Applies analytical methods as part of the development platform for biosimilars.
Commercial supply capabilities
Supports commercial supply activities including import, batch certification, and release for supply within the EU.
Capabilities
- Assays and studies
- Analytical methods · Laboratory tests · Comparative analysis · Preclinical laboratory tests
- Scale and capacity
- Fermentation tanks
- Therapeutic areas
- Eye diseases · Cancer · Rheumatoid arthritis · Psoriasis · Macular degeneration · Diabetes · MS · Arthritis
Modalities and species
- Modalities
- Recombinant protein · Biosimilar
- Species and models
- E. coli · Mammal cells · Yeast cells · Plant cells · Animal cells
Industries served
- Biotechnology
- Pharmaceuticals
Company
- Founded
- 2019
- Quality
- EU Good Manufacturing Practice (batch certification and release for supply within the EU) · GMP authorization from the Swedish Medic (import medicinal products from countries outside the EU/EEA and perform batch certification and release)
Locations
- Based in
- Solna, Sweden
- Sites
- Stockholm, Sweden
- Serves
- EU, USA, US
Similar labs
Work here? Claim this listing